Committee opinion no. 504: Screening and diagnosis of gestational diabetes mellitus.
Committee opinion no. 504: Screening and diagnosis of gestational diabetes mellitus.
复制标题
DOI：
10.1097/aog.0b013e3182310cc3
复制
发表时间：
2011-09-01
影响因子：
7.2
通讯作者：
中科院分区：
文献类型：
--
作者：
妊娠期糖尿病（GDM），定义为在妊娠期间开始或首次发现的碳水化合物不耐受，与母体、胎儿和新生儿风险增加有关。GDM在美国的患病率正在上升，可能是因为超重和肥胖的比例在上升。对于筛查和诊断GDM的理想方法的普遍推荐仍然难以捉摸。目前，产科实践委员会继续建议采取两步筛查和诊断方法。所有孕妇都应筛查GDM，无论是通过病史、临床危险因素，还是在妊娠24-28周进行50g、1小时葡萄糖激发试验。GDM的诊断可根据100g， 3小时口服葡萄糖耐量试验结果进行，有证据表明治疗可改善预后。
Gestational diabetes mellitus (GDM), defined as carbohydrate intolerance that begins or is first recognized during pregnancy, is associated with increased maternal, fetal, and neonatal risks. The prevalence of GDM in the United States is increasing, probably because of increasing rates of overweight and obesity. A universal recommendation for the ideal approach for screening and diagnosis of GDM remains elusive. At this time, the Committee on Obstetric Practice continues to recommend a two-step approach to screening and diagnosis. All pregnant women should be screened for GDM, whether by patient history, clinical risk factors, or a 50-g, 1-hour glucose challenge test at 24-28 weeks of gestation. The diagnosis of GDM can be made based on the result of the 100-g, 3-hour oral glucose tolerance test, for which there is evidence that treatment improves outcome.